Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.88B
| $2.16M | ﹤0.01% |
32,760
+1,697
| +5% | +$116K |
|
5127
Magna International
MGA
$19B
| $2.16M | ﹤0.01% |
40,407
+36,435
| +917% | +$2.11M |
|
|
CHCT
5128
Community Healthcare Trust
CHCT
$427M
| $2.16M | ﹤0.01% |
59,139
-51,536
| -47% | -$2.01M |
|
5129
PUT
Fulgent Genetics
FLGT
$515M
| $2.16M | ﹤0.01% |
69,300
+600
| +0.9% | +$19.3K |
|
5130
PUT
Trex
TREX
$4.96B
| $2.16M | ﹤0.01% |
44,400
-280,300
| -86% | -$14.2M |
|
|
ITCI
5131
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.16M | ﹤0.01% |
39,900
-11,300
| -22% | -$546K |
|
5132
PUT
Progyny
PGNY
$1.96B
| $2.16M | ﹤0.01% |
67,200
+40,400
| +151% | +$1.33M |
|
5133
PUT
AerSale
ASLE
$275M
| $2.16M | ﹤0.01% |
125,300
-25,800
| -17% | -$459K |
|
5134
PUT
ProShares Ultra QQQ
QLD
$14.6B
| $2.16M | ﹤0.01% |
87,000
+30,400
| +54% | +$645K |
|
5135
CALL
Chefs' Warehouse
CHEF
$4.58B
| $2.16M | ﹤0.01% |
63,300
+4,000
| +7% | +$141K |
|
|
MREO
5136
Mereo BioPharma
MREO
$48.8M
| $2.15M | ﹤0.01% |
3,047,960
-14,372
| -0.5% | -$12.9K |
|
5137
CALL
Bankunited
BKU
$3.41B
| $2.15M | ﹤0.01% |
95,400
+94,200
| +7,850% | +$3.07M |
|
5138
CALL
Blue Owl Capital
OWL
$18.6B
| $2.15M | ﹤0.01% |
194,300
+51,000
| +36% | +$611K |
|
|
ICPT
5139
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.15M | ﹤0.01% |
159,959
-317,170
| -66% | -$5.49M |
|
|
XDJA
5140
DELISTED
Innovator U.S. Equity Accelerated ETF - January
XDJA
| $2.14M | ﹤0.01% |
100,313
-8,803
| -8% | -$183K |
|
5141
PUT
Build-A-Bear
BBW
$470M
| $2.14M | ﹤0.01% |
92,200
-43,300
| -32% | -$1.01M |
|
5142
MSCI
MSCI
$40.7B
| $2.14M | ﹤0.01% |
3,826
-170,818
| -98% | -$90.4M |
|
5143
ETRACS Alerian MLP Infrastructure Index ETN Series B due Apr 2 2040
MLPB
$255M
| $2.14M | ﹤0.01% |
112,243
+78,000
| +228% | +$1.5M |
|
5144
CALL
Coursera
COUR
$1.52B
| $2.14M | ﹤0.01% |
185,800
-71,300
| -28% | -$923K |
|
5145
Precision BioSciences
DTIL
$206M
| $2.14M | ﹤0.01% |
94,580
+28,879
| +44% | +$952K |
|
5146
CALL
Community Health Systems
CYH
$412M
| $2.14M | ﹤0.01% |
436,000
+357,800
| +458% | +$1.88M |
|
5147
Luxfer Holdings
LXFR
$458M
| $2.14M | ﹤0.01% |
126,375
+7,396
| +6% | +$119K |
|
|
WHWK
5148
Whitehawk Therapeutics
WHWK
$266M
| $2.13M | ﹤0.01% |
294,793
-2,201
| -0.7% | -$23.5K |
|
5149
PUT
Tronox
TROX
$929M
| $2.13M | ﹤0.01% |
148,400
+99,300
| +202% | +$1.53M |
|
5150
PUT
Array Technologies
ARRY
$758M
| $2.13M | ﹤0.01% |
97,500
-50,900
| -34% | -$1.04M |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.